Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of hypercholesterolemia.

D R Illingworth1

  • 1Department of Medicine, Oregon Health Sciences University, Portland, USA. illingwo@ohsu.edu

The Medical Clinics of North America
|February 24, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type IIa hypercholesterolemia.

Digestive diseases and sciences·2005
Same author

Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus.

The American journal of cardiology·2001
Same author

A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.

Current medical research and opinion·2001
Same author

HMG-CoA reductase inhibitors.

Advances in protein chemistry·2001
Same author

Effect of a very-high-fiber vegetable, fruit, and nut diet on serum lipids and colonic function.

Metabolism: clinical and experimental·2001
Same author

Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia.

Journal of lipid research·2000

Treating hyperlipidemia effectively lowers cardiovascular risk. Clinical trials support diet and drug therapies to reduce LDL cholesterol, especially in high-risk patients, preventing disease progression.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Pharmacology

Background:

  • Hyperlipidemia poses significant cardiovascular risks.
  • Evidence-based medicine confirms benefits of lipid-lowering therapies.
  • National guidelines exist for hypolipidemic drug use.

Purpose of the Study:

  • To review clinical trial data on diet and drug therapy for hyperlipidemia.
  • To discuss therapeutic approaches focused on lowering LDL cholesterol.
  • To highlight the importance of individualized treatment goals.

Main Methods:

  • Review of clinical trial data on lipid-lowering therapies.
  • Analysis of national guidelines for hypolipidemic drug use.
  • Discussion of therapeutic strategies for various patient risk groups.

Related Experiment Videos

Main Results:

  • Diet and drug therapies are effective in reducing LDL cholesterol.
  • Lower LDL cholesterol targets are recommended for patients with atherosclerosis or diabetes.
  • Therapeutic goals include preventing progression and inducing regression of atherosclerosis.

Conclusions:

  • Lipid-lowering therapy offers significant clinical benefit for hyperlipidemia.
  • Effective treatment and long-term follow-up are crucial for patient outcomes.
  • Individualized treatment strategies are essential for managing lipoprotein disorders.